SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-047136
Filing Date
2020-02-25
Accepted
2020-02-25 06:07:27
Documents
4
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d802949d6k.htm 6-K 306266
2 GRAPHIC g802949g81f81.jpg GRAPHIC 23556
3 GRAPHIC g802949g89x06.jpg GRAPHIC 27169
4 GRAPHIC g802949kazia.jpg GRAPHIC 5068
  Complete submission text file 0001193125-20-047136.txt   384628
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 20647159
SIC: 2834 Pharmaceutical Preparations